A definitive randomised controlled trial of arteriovenous fistula (AVF) versus arteriovenous grafts (AVG) has been advocated for more than a decade, but as yet, none has been completed. The aim of this article is to summarise the theoretical barriers, review the difficulties in trial design and practicalities that have thus far prevented this from occurring.
SchmidliJWidmerMKBasileC, et al. Editor’s choice - vascular access: 2018 clinical practice guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg2018; 55: 757–818.
2.
LokCHuberTLeeT, et al. KDOQI clinical practice guideline for vascular access: 2019 update. Am J Kidney Dis2020; 75: S1–S164.
3.
HuberTSBerceliSAScaliST, et al. Arteriovenous fistula maturation, functional patency, and intervention rates. JAMA Surg2021; 156: 1111–1118.
4.
StoumposSTraynorJPMetcalfeW, et al. A national study of autogenous arteriovenous access use and patency in a contemporary hemodialysis population. J Vasc Surg2019; 69: 1889–1898.
5.
BylsmaLCGageSMReichertH, et al. Arteriovenous fistulae for haemodialysis: a systematic review and meta-analysis of efficacy and safety outcomes. Eur J Vasc Endovasc Surg2017; 54: 513–522.
6.
AlmasriJAlsawasMMainouM, et al. Outcomes of vascular access for hemodialysis: a systematic review and meta-analysis. J Vasc Surg2016; 64: 236–243.
7.
WoodsideKJBellSMukhopadhyayP, et al. Arteriovenous fistula maturation in prevalent hemodialysis patients in the United States: a national study. Am J Kidney Dis2018; 71: 793–801.
8.
ArhuideseIJOrandiBJNejimB, et al. Utilization, patency, and complications associated with vascular access for hemodialysis in the United States. J Vasc Surg2018; 68: 1166–1174.
9.
CastroVFarberAZhangY, et al. Reasons for long-term tunneled dialysis catheter use and associated morbidity. J Vasc Surg2021; 73: 588–592.
10.
StoumposSMarkPB.Should we ligate arteriovenous fistulas in asymptomatic patients after kidney transplantation?Circulation2019; 139: 2819–2821.
11.
StoumposSRankinAHall BarrientosP, et al. Interrogating the haemodynamic effects of haemodialysis arteriovenous fistula on cardiac structure and function. Sci Rep2021; 11: 18102.
12.
KingsmoreDBStevensonKSRicharzS, et al. Patient characteristics predict patency of early-cannulation arteriovenous grafts. Sci Rep2021; 11: 10743.
13.
Al ShakarchiJHoustonGInstonN. Early cannulation grafts for haemodialysis: a systematic review. J Vasc Access2015; 16: 493–497.
14.
Al ShakarchiJInstonN. Early cannulation grafts for haemodialysis: an updated systematic review. J Vasc Access2019; 20: 123–127.
15.
LeeHWAllonM.When should a patient receive an arteriovenous graft rather than a fistula?Semin Dial2013; 26: 6–10.
16.
DisbrowDECullDLCarstenCG3rd, et al. Comparison of arteriovenous fistulas and arteriovenous grafts in patients with favorable vascular anatomy and equivalent access to health care: is a reappraisal of the Fistula First Initiative indicated?J Am Coll Surg2013; 216: 679–685; discussion 85–6.
17.
SgroiMDPatelMSWilsonSE, et al. The optimal initial choice for permanent arteriovenous hemodialysis access. J Vasc Surg2013; 58: 539–548.
18.
AllonMRobbinML. Resolved: fistulas are preferred to grafts as initial vascular access for dialysis. Con. J Am Soc Nephrol2008; 19: 1632–1633.
19.
BesarabA.Resolved: fistulas are preferred to grafts as initial vascular access for dialysis. Pro. J Am Soc Nephrol2008; 19: 1629–1631.
20.
TayebiPKazemzadehGModagheghMHS, et al. Brachio-basilic upper arm transposition fistulas vs. prosthetic brachio-axillary vascular access grafts-which one is preferred for hemodialysis?Hemodial Int2020; 24: 182–187.
21.
RobinsonTGearyRLDavisRP, et al. Arteriovenous fistula versus graft access strategy in older adults receiving hemodialysis: a pilot randomized trial. Kidney Med2021; 3: 248–256.e1.
22.
RicharzSGreenwoodSKingsmoreDB, et al. Validation of a vascular access specific quality of life measure (VASQoL). J Vasc Access2023; 24: 702–714.
23.
SutariaRGilbertJA.Single-centre experience of an early cannulation graft for haemodialysis access. J Vasc Access2020; 21: 883–891.
24.
MamodeNCalderF.Improving outcomes in dialysis fistulae. Lancet2016; 388: 1029–1030.
25.
DemberLMBeckGJAllonM, et al. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA2008; 299: 2164–2171.
26.
ThomasECBassSBSiminoffLA.Beyond rationality: expanding the practice of shared decision making in modern medicine. Soc Sci Med2021; 277: 113900.
27.
BoeninkRKramerAMasoudS, et al. International comparison and time trends of first kidney transplant recipient characteristics across Europe: an ERA Registry study. Nephrol Dial Transplant. Epub ahead of print 31 August 2023. DOI: 10.1093/ndt/gfad189.
28.
ChanCTBlankestijnPJDemberLM, et al. Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int2019; 96: 37–47.
29.
CooperBABranleyPBulfoneL, et al. A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med2010; 363: 609–619.
30.
PisoniRLZepelLPortFK, et al. Trends in US vascular access use, patient preferences, and related practices: an update from the US DOPPS practice monitor with international comparisons. Am J Kidney Dis2015; 65: 905–915.
31.
RobinsonBMAkizawaTJagerKJ, et al. Factors affecting outcomes in patients reaching end-stage kidney disease worldwide: differences in access to renal replacement therapy, modality use, and haemodialysis practices. Lancet2016; 388: 294–306.
32.
MureaMDeiraJKalantar-ZadehK, et al. The spectrum of kidney dysfunction requiring chronic dialysis therapy: implications for clinical practice and future clinical trials. Semin Dial2022; 35: 107–116.
33.
MureaMFlytheJEAnjayR, et al. Kidney dysfunction requiring dialysis is a heterogeneous syndrome: we should treat it like one. Curr Opin Nephrol Hypertens2022; 31: 92–99.
34.
ChenJLiuYChenX, et al. Assessment of dialysis initiation by a fuzzy mathematics equation (ADIFE): a study protocol for a randomised controlled trial. BMJ Open2019; 9: e023162.
35.
LiuYWangDChenX, et al. An equation based on fuzzy mathematics to assess the timing of haemodialysis initiation. Sci Rep2019; 9: 5871.
36.
Al-BalasAShariffSLeeT, et al. Clinical outcomes and economic impact of starting hemodialysis with a catheter after predialysis arteriovenous fistula creation. Am J Nephrol2019; 50: 221–227.
37.
OlaitanAAshmanNHomerK, et al. Predictors of late presentation to renal dialysis: a cohort study of linked primary and secondary care records in East London. BMJ Open2019; 9: e028431.
38.
GorrizJLSanchoAPallardoLM, et al. Longer pre-dialysis nephrological care is associated with improved long-term survival of dialysis patients. More facts. Nephrol Dial Transplant2002; 17: 1354–1355.
39.
MarronBOrtizAde SequeraP, et al. Impact of end-stage renal disease care in planned dialysis start and type of renal replacement therapy—a Spanish multicentre experience. Nephrol Dial Transplant2006; 21 Suppl 2: ii51–ii55.
40.
CaskeyFJWordsworthSBenT, et al. Early referral and planned initiation of dialysis: what impact on quality of life?Nephrol Dial Transplant2003; 18: 1330–1338.
41.
RoyDChowdhuryARPandeS, et al. Evaluation of unplanned dialysis as a predictor of mortality in elderly dialysis patients: a retrospective data analysis. BMC Nephrol2017; 18: 364.
42.
SattariSASattariARHicksCW, et al. Primary balloon angioplasty versus hydrostatic dilation for arteriovenous fistula creation in patients with small-caliber cephalic veins: a systematic review and meta-analysis. Ann Vasc Surg2022; 87: 351–361.
43.
ZhouYWuH.Comparison of end-to-side versus side-to-side anastomosis in upper limb arteriovenous fistula in hemodialysis patients: a systematic review and meta-analysis. Front Surg2022; 9: 1079291.
44.
BahiM.Effect of systemic intraoperative heparin use on upper extremity arteriovenous fistula patency in end-stage renal disease patients. ScientificWorldJournal2021; 2021: 2965743.
45.
ShemeshDGoldinIHijaziJ, et al. A prospective randomized study of heparin-bonded graft (Propaten) versus standard graft in prosthetic arteriovenous access. J Vasc Surg2015; 62: 115–122.
46.
KingsmoreDJacksonAStevensonK.A critical review of surgical strategies to minimise venous stenosis in arteriovenous grafts. J Vasc Access. Epub ahead of print 30 November 2021. DOI: 10.1177/11297298211060944.
47.
KamarFQuinnRROliverMJ, et al. Outcomes of the first and second hemodialysis fistula: a cohort study. Am J Kidney Dis2019; 73: 62–71.
48.
WooKUlloaJAllonM, et al. Establishing patient-specific criteria for selecting the optimal upper extremity vascular access procedure. J Vasc Surg2017; 65: 1089–1103.e1.
49.
WooKLokCE.New insights into dialysis vascular access: what is the optimal vascular access type and timing of access creation in CKD and dialysis patients?Clin J Am Soc Nephrol2016; 11: 1487–1494.
50.
ZonnebeldNTordoirJHMvan LoonMM, et al. Pre-operative patient specific flow predictions to improve haemodialysis arteriovenous fistula maturation (Shunt Simulation Study): a randomised controlled trial. Eur J Vasc Endovasc Surg2020; 60: 98–106.
51.
LeeTQianJZZhangY, et al. Long-term outcomes of arteriovenous fistulas with unassisted versus assisted maturation: a retrospective national hemodialysis cohort study. J Am Soc Nephrol2019; 30: 2209–2218.
52.
Al-BalasALeeTYoungCJ, et al. Choice of a second vascular access in hemodialysis patients whose initial arteriovenous fistula failed to mature. J Vasc Surg2018; 68: 1858–1864.e1.
53.
Al-BalasALeeTYoungCJ, et al. The clinical and economic effect of vascular access selection in patients initiating hemodialysis with a catheter. J Am Soc Nephrol2017; 28: 3679–3687.
54.
LeeTUllahAAllonM, et al. Decreased cumulative access survival in arteriovenous fistulas requiring interventions to promote maturation. Clin J Am Soc Nephrol2011; 6: 575–581.
55.
ShingarevRBarker-FinkelJAllonM.Association of hemodialysis central venous catheter use with ipsilateral arteriovenous vascular access survival. Am J Kidney Dis2012; 60: 983–989.
56.
LowrieEGLairdNMParkerTF, et al. Effect of the hemodialysis prescription on patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med1981; 305: 1176–1181.
57.
GotchFASargentJA.A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int1985; 28: 526–534.
58.
EknoyanGBeckGJCheungAK, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med2002; 347: 2010–2019.
59.
AshbyDBormanNBurtonJ, et al. Renal association clinical practice guideline on haemodialysis. BMC Nephrol2019; 20: 379.
60.
GreenwoodSKingsmoreDRicharzS, et al. ‘It’s about what I’m able to do’: using the capabilities approach to understand the relationship between quality of life and vascular access in patients with end-stage kidney failure. SSM Qual Res Health2022; 2: 100187.
61.
NoordzijMLeffondreKvan StralenKJ, et al. When do we need competing risks methods for survival analysis in nephrology?Nephrol Dial Transplant2013; 28: 2670–2677.
62.
KaufmanJLGarbJLBermanJA, et al. A prospective comparison of two expanded polytetrafluoroethylene grafts for linear forearm hemodialysis access: does the manufacturer matter?J Am Coll Surg1997; 185: 74–79.
